Report from the 4-th International Symposium on Targeted Anticancer Therapies, Amsterdam March 16-18, 2006 (TAT 2006)
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 4
Abstract
Authors and Affiliations
Krzysztof Leśniewski-Kmak
Keywords
Related Articles
- EP ID EP154600
- DOI -
- Views 60
- Downloads 0
The activity of N-acetyl-β-D-hexosaminidase in serum and urine of patients with pancreatic cancer
Background: N-acetyl-β-D-hexosaminidase (HEX) is lysosomal exoglycosidase (EC 3.2.1.52), which releases N-acetyloheksozoamines from non reducing ends of oligosaccharide chains of glycoconjungates (glycoproteins, glycoli...
Utilization of Radium 226 from the oncology center - evaluation of staff exposure
226Ra found application in oncological therapy due to its long half-life and the type of emitted radiation. After many years of application it was replaced by less radiotoxic short-lived isotopes. In some oncology centre...
The role of endocrine therapy in adjuvant management for premenopausal breast cancer patients
The efficacy of adjuvant treatment in some cases of early breast cancer is unquestionable. In 1998, the first report about the role of adjuvant treatment was published. Opinion leaders, such as the International Expert...
Toxicity of g-csf given during radiotherapy in lung cancer
Introduction: The use of white blood cell growth factors (WBCGF) (g-csf, gm-csf) is recommended in chemotherapy-induced febrile neutropenia or prophylactically for cases treated with some chemotherapy regimens. Due to la...
Leczenie celowane chorych na raka jelita grubego – aktualny stan wiedzy
Ostatnie osiągnięcia w dziedzinie terapii celowanej przyniosły chorym na raka jelita grubego dalszą poprawę przeżycia. Szczególne znaczenie kliniczne uzyskały 2 przeciwciała monoklonalne skierowane przeciw naczyniowemu...